Clinical outcomes of tucidinostat-based therapy after prior CDK4/6 inhibitor progression in hormone receptor-positive heavily pretreated metastatic breast cancer
| Autor: | Zhou, Jinmei, Wu, Xuexue, Zhang, Huiqiang, Wang, Xiaobo, Yuan, Yang, Zhang, Shaohua, Jiang, Zefei, Wang, Tao |
|---|---|
| Zdroj: | In The Breast December 2022 66:255-261 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect